North Carolina's BioKier, Inc. Takes A Shot At A New Kind Of Diabetes Drug
8/25/2014 6:53:59 AM
Diabetics know all too well that needle sticks are a routine part of managing their disease. Insulin injections have been part of the diabetes standard of care for decades. And in recent years, a new class of injectable drugs have emerged to help patients regulate their blood sugar levels.
Chapel Hill, NC, drug developer BioKier is beginning human tests of a drug that, if successful, could replace these injection therapies with a pill that coaxes the body to regulate blood sugar levels on its own, says George Szewczyk, BioKier founder and CEO.
Help employers find you! Check out all the jobs and post your resume.
comments powered by